Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$223.95
-0.4%
$232.90
$218.75
$251.99
$64.30B0.351.51 million shs2.09 million shs
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$68.52
+0.2%
$71.92
$58.93
$96.12
$40.28B1.124.50 million shs4.45 million shs
ResMed Inc. stock logo
RMD
ResMed
$220.09
-2.5%
$236.63
$172.19
$263.05
$32.32B0.74970,321 shs775,556 shs
STERIS plc stock logo
STE
STERIS
$224.36
-1.6%
$218.32
$197.82
$248.24
$22.04B0.92530,911 shs559,632 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-0.53%-0.09%-2.35%-1.42%-5.83%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
+0.05%-6.00%-3.56%-7.37%-24.63%
ResMed Inc. stock logo
RMD
ResMed
-2.39%-1.64%-7.74%-9.25%+13.58%
STERIS plc stock logo
STE
STERIS
-1.65%-1.38%+0.09%+3.70%-4.04%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.8623 of 5 stars
2.55.04.24.03.63.31.3
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
4.8267 of 5 stars
3.25.00.04.03.32.52.5
ResMed Inc. stock logo
RMD
ResMed
4.6764 of 5 stars
3.33.03.34.52.71.71.3
STERIS plc stock logo
STE
STERIS
4.4247 of 5 stars
2.43.03.33.83.61.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
3.00
Buy$278.2924.26% Upside
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
2.42
Hold$79.9516.68% Upside
ResMed Inc. stock logo
RMD
ResMed
2.67
Moderate Buy$243.8210.78% Upside
STERIS plc stock logo
STE
STERIS
2.80
Moderate Buy$258.7515.33% Upside

Current Analyst Ratings Breakdown

Latest STE, BDX, EW, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/5/2025
ResMed Inc. stock logo
RMD
ResMed
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
3/5/2025
ResMed Inc. stock logo
RMD
ResMed
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$250.00 ➝ $240.00
2/14/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$278.00 ➝ $279.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$88.00 ➝ $90.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$68.00 ➝ $71.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Strong Sell
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$85.00 ➝ $85.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $73.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$75.00 ➝ $73.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $75.00
2/6/2025
STERIS plc stock logo
STE
STERIS
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$265.00 ➝ $265.00
(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.64B3.12$20.81 per share10.76$89.57 per share2.50
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$5.44B7.41$2.53 per share27.04$11.08 per share6.18
ResMed Inc. stock logo
RMD
ResMed
$4.93B6.56$8.72 per share25.23$35.77 per share6.15
STERIS plc stock logo
STE
STERIS
$5.40B4.08$14.26 per share15.73$65.43 per share3.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$6.0237.2014.321.638.47%15.74%7.29%5/1/2025 (Estimated)
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$4.17B$6.979.8324.924.8272.93%19.40%14.37%4/24/2025 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$1.02B$8.4725.9821.241.5325.34%26.17%18.60%4/24/2025 (Estimated)
STERIS plc stock logo
STE
STERIS
$378.24M$4.7147.6422.59N/A8.66%13.91%8.64%5/14/2025 (Estimated)

Latest STE, BDX, EW, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/11/2025Q4 2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.55$0.59+$0.04$0.65$1.36 billionN/A
2/5/2025Q1 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.00$3.43+$0.43$1.04$5.13 billionN/A
2/5/2025Q3 2025
STERIS plc stock logo
STE
STERIS
$2.33$2.32-$0.01$1.75$1.38 billionN/A
1/30/2025Q2 2025
ResMed Inc. stock logo
RMD
ResMed
$2.29$2.43+$0.14$2.34$1.27 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.161.86%+5.00%69.10%53 Years
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$2.120.96%+7.63%25.03%13 Years
STERIS plc stock logo
STE
STERIS
$2.281.02%+9.51%48.41%20 Years

Latest STE, BDX, EW, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/28/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.041.67%3/10/20253/10/20253/31/2025
1/28/2025
STERIS plc stock logo
STE
STERIS
quarterly$0.571.03%2/20/20252/20/20253/21/2025
1/30/2025
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.530.9%2/13/20252/13/20253/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.69
1.13
0.63
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.06
3.46
2.89
ResMed Inc. stock logo
RMD
ResMed
0.13
3.33
2.29
STERIS plc stock logo
STE
STERIS
0.32
2.13
1.40

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
79.46%
ResMed Inc. stock logo
RMD
ResMed
54.98%
STERIS plc stock logo
STE
STERIS
94.69%

Insider Ownership

CompanyInsider Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.36%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
1.29%
ResMed Inc. stock logo
RMD
ResMed
0.71%
STERIS plc stock logo
STE
STERIS
1.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000287.14 million286.10 millionOptionable
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
17,300587.90 million582.19 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
9,980146.87 million145.82 millionOptionable
STERIS plc stock logo
STE
STERIS
18,17998.25 million97.13 millionOptionable

Recent News About These Companies

STERIS plc stock logo
Amundi Purchases 100,740 Shares of STERIS plc (NYSE:STE)
STERIS plc stock logo
STERIS plc (NYSE:STE) Shares Purchased by Assetmark Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$223.95 -0.97 (-0.43%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$223.46 -0.49 (-0.22%)
As of 03/12/2025 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$68.52 +0.13 (+0.19%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$68.52 -0.01 (-0.01%)
As of 03/12/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

ResMed stock logo

ResMed NYSE:RMD

$220.09 -5.70 (-2.53%)
Closing price 03/12/2025 03:58 PM Eastern
Extended Trading
$220.93 +0.84 (+0.38%)
As of 03/12/2025 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

STERIS stock logo

STERIS NYSE:STE

$224.36 -3.70 (-1.62%)
Closing price 03/12/2025 03:58 PM Eastern
Extended Trading
$224.44 +0.08 (+0.03%)
As of 03/12/2025 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.